EC
CTMX icon

EcoR1 Capital’s CytomX Therapeutics CTMX Stock Holding History

EcoR1 Capital’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,101
Closed -$8K – 53
2020
Q1 		$8K Sell
1,101
-408,899
-100% -$2.85M ﹤0.01% 51
2019
Q4 		$3.41M Buy
+410,000
New +$2.77M 0.32% 41
2017
Q4 		– Sell
-829,771
Closed -$15.1M – 34
2017
Q3 		$15.1M Buy
829,771
+34,802
+4% +$543K 2.06% 13
2017
Q2 		$12.3M Hold
794,969
– – 2.84% 11
2017
Q1 		$13.7M Buy
+794,969
New +$10.5M 3.8% 9

Other funds holding CTMX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return